GLP-1 drugs and 'Ozempic babies': what the evidence says

What did @drshawnaruple actually say?

The creator, an OB-GYN, says GLP-1 medications are triggering a pregnancy surge, and the likely explanation is weight-related improvements in ovulation and insulin resistance, especially in women with PCOS. Her practical takeaway: if you're on a GLP-1 and not trying to conceive, use contraception, because assuming you can't get pregnant may no longer be accurate. That's the whole claim, and it's reasonably constructed for a short-form video.

She doesn't name a specific drug, doesn't cite a study, and doesn't exaggerate the mechanism. The framing as a "baby boom" is catchy, but she walks it back immediately with a clinical explanation rather than letting the hype do the work. For TikTok health content, this is a relatively disciplined performance.

Does the science back this up?

Mostly yes, with important caveats. The weight loss connection to improved ovulation is well-established. The GLP-1-specific fertility data is still early, observational, and not cleanly separated from the effects of weight loss itself.

A 2023 analysis published in Annals of Internal Medicine (Alsdurf et al.) flagged that semaglutide users were significantly more likely to report unintended pregnancy than users of other weight-loss interventions, but the data came from insurance claims, not a controlled trial. A 2024 preprint from researchers at Weill Cornell found similar signals in a large administrative dataset. These aren't randomized controlled trials. They're pattern-recognition data, which means confounding is real. Women losing weight on GLP-1s may simply be resuming ovulation because of weight loss, not because of any direct action of the drug on the reproductive system.

Separately, semaglutide may reduce the effectiveness of oral contraceptives by slowing gastric emptying, which changes drug absorption timing. A small pharmacokinetic study (Marbury et al., 2011, Clinical Pharmacokinetics, conducted with liraglutide) suggested this is a real concern, though the magnitude in real-world users isn't fully quantified.

What did they get wrong (or right)?

The creator gets the core mechanism right. Weight loss improving ovulatory function is textbook reproductive endocrinology. She's also correct that insulin resistance in PCOS is part of the picture, and GLP-1 receptor agonists do appear to improve insulin sensitivity (Jensterle et al., 2022, Obesity Reviews), which could independently restore ovarian function beyond just weight loss.

What she doesn't address, and should have, is that the "Ozempic baby boom" framing suggests a proven direct fertility effect of the drug. The honest answer is we don't know yet whether GLP-1s are doing something biologically distinct from what caloric restriction alone would do. The claim is plausible, not proven. She also doesn't mention the gastric emptying issue with oral contraceptives, which is arguably the most actionable clinical point for women on the pill who are also taking a GLP-1. That omission matters.

On balance: she got the direction right. She just treated preliminary signals as more settled than they are.

What should you actually know?

If you're on a GLP-1 medication and relying on oral contraceptives, talk to your prescriber about whether your birth control method is still adequate. The drug's effect on gastric emptying is real, and while it's not confirmed to make pills clinically ineffective, the uncertainty is large enough that a backup method or switching to a non-oral form of contraception is a reasonable conversation to have.

If you have PCOS and have been told fertility is unlikely, GLP-1-related weight loss may genuinely change that picture. Restored ovulation can happen faster than expected once metabolic function improves. This doesn't mean GLP-1 drugs are fertility treatments. They are not approved for that, and the evidence doesn't support using them as such.

Semaglutide and tirzepatide are also contraindicated in pregnancy. If you become pregnant while on one of these drugs, stop the medication and contact your provider immediately. The animal data on fetal harm is a serious red flag, and human safety data in pregnancy is essentially nonexistent.

Bottom line

This video does more right than wrong. The creator offers a biologically coherent explanation, avoids overclaiming, and lands on a genuinely useful clinical message: use reliable contraception if you're on a GLP-1 and not trying to conceive. The "baby boom" framing is a little loose with the evidence, and the oral contraceptive absorption issue deserved a mention. But for 60 seconds on TikTok from a practicing OB-GYN, this is a fair representation of a real and emerging clinical concern.